Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100076167> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2100076167 endingPage "964" @default.
- W2100076167 startingPage "960" @default.
- W2100076167 abstract "OBJECTIVE: To determine the degree to which alpha-glucosidase inhibitors, with their unique mode of action primarily reducing postprandial hyperglycemia, offer an additional therapeutic approach in the long-term treatment of type 2 diabetes. RESEARCH DESIGN AND METHODS: We studied 1,946 patients (63% men) who were previously enrolled in the U.K. Prospective Diabetes Study (UKPDS). The patients were randomized to acarbose (n = 973), titrating to a maximum dose of 100 mg three times per day, or to matching placebo (n = 973). Mean +/- SD age was 59 +/- 9 years, body weight 84 +/- 17 kg, diabetes duration 7.6 +/- 2.9 years, median (interquartile range) HbA1c 7.9% (6.7-9.5), and fasting plasma glucose (FPG) 8.7 mmol/l (6.8-11.1). Fourteen percent of patients were treated with diet alone, 52% with monotherapy, and 34% with combined therapy. Patients were monitored in UKPDS clinics every 4 months for 3 years. The main outcome measures were HbA1c, FPG, body weight, compliance with study medication, incidence of side effects, and frequency of major clinical events. RESULTS: At 3 years, a lower proportion of patients were taking acarbose compared with placebo (39 vs. 58%, P < 0.0001), the main reasons for noncompliance being flatulence (30 vs. 12%, P < 0.0001) and diarrhea (16 vs. 8%, P < 0.05). Analysis by intention to treat showed that patients allocated to acarbose, compared with placebo, had 0.2% significantly lower median HbA1c at 3 years (P < 0.001). In patients remaining on their allocated therapy, the HbA1c difference at 3 years (309 acarbose, 470 placebo) was 0.5% lower median HbA1c (8.1 vs. 8.6%, P < 0.0001). Acarbose appeared to be equally efficacious when given in addition to diet alone; in addition to monotherapy with a sulfonylurea, metformin, or insulin; or in combination with more complex treatment regimens. No significant differences were seen in FPG, body weight, incidence of hypoglycemia, or frequency of major clinical events. CONCLUSIONS: Acarbose significantly improved glycemic control over 3 years in patients with established type 2 diabetes, irrespective of concomitant therapy for diabetes. Careful titration of acarbose is needed in view of the increased noncompliance rate seen secondary to the known side effects." @default.
- W2100076167 created "2016-06-24" @default.
- W2100076167 creator A5007719363 @default.
- W2100076167 creator A5009176775 @default.
- W2100076167 creator A5049740900 @default.
- W2100076167 date "1999-06-01" @default.
- W2100076167 modified "2023-10-16" @default.
- W2100076167 title "A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)" @default.
- W2100076167 cites W2261796800 @default.
- W2100076167 doi "https://doi.org/10.2337/diacare.22.6.960" @default.
- W2100076167 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10372249" @default.
- W2100076167 hasPublicationYear "1999" @default.
- W2100076167 type Work @default.
- W2100076167 sameAs 2100076167 @default.
- W2100076167 citedByCount "400" @default.
- W2100076167 countsByYear W21000761672012 @default.
- W2100076167 countsByYear W21000761672013 @default.
- W2100076167 countsByYear W21000761672014 @default.
- W2100076167 countsByYear W21000761672015 @default.
- W2100076167 countsByYear W21000761672016 @default.
- W2100076167 countsByYear W21000761672017 @default.
- W2100076167 countsByYear W21000761672018 @default.
- W2100076167 countsByYear W21000761672019 @default.
- W2100076167 countsByYear W21000761672020 @default.
- W2100076167 countsByYear W21000761672021 @default.
- W2100076167 countsByYear W21000761672022 @default.
- W2100076167 countsByYear W21000761672023 @default.
- W2100076167 crossrefType "journal-article" @default.
- W2100076167 hasAuthorship W2100076167A5007719363 @default.
- W2100076167 hasAuthorship W2100076167A5009176775 @default.
- W2100076167 hasAuthorship W2100076167A5049740900 @default.
- W2100076167 hasConcept C119060515 @default.
- W2100076167 hasConcept C126322002 @default.
- W2100076167 hasConcept C134018914 @default.
- W2100076167 hasConcept C142724271 @default.
- W2100076167 hasConcept C168563851 @default.
- W2100076167 hasConcept C188816634 @default.
- W2100076167 hasConcept C204787440 @default.
- W2100076167 hasConcept C27081682 @default.
- W2100076167 hasConcept C2776617576 @default.
- W2100076167 hasConcept C2777180221 @default.
- W2100076167 hasConcept C2778199505 @default.
- W2100076167 hasConcept C2780473172 @default.
- W2100076167 hasConcept C555293320 @default.
- W2100076167 hasConcept C71924100 @default.
- W2100076167 hasConcept C90924648 @default.
- W2100076167 hasConceptScore W2100076167C119060515 @default.
- W2100076167 hasConceptScore W2100076167C126322002 @default.
- W2100076167 hasConceptScore W2100076167C134018914 @default.
- W2100076167 hasConceptScore W2100076167C142724271 @default.
- W2100076167 hasConceptScore W2100076167C168563851 @default.
- W2100076167 hasConceptScore W2100076167C188816634 @default.
- W2100076167 hasConceptScore W2100076167C204787440 @default.
- W2100076167 hasConceptScore W2100076167C27081682 @default.
- W2100076167 hasConceptScore W2100076167C2776617576 @default.
- W2100076167 hasConceptScore W2100076167C2777180221 @default.
- W2100076167 hasConceptScore W2100076167C2778199505 @default.
- W2100076167 hasConceptScore W2100076167C2780473172 @default.
- W2100076167 hasConceptScore W2100076167C555293320 @default.
- W2100076167 hasConceptScore W2100076167C71924100 @default.
- W2100076167 hasConceptScore W2100076167C90924648 @default.
- W2100076167 hasIssue "6" @default.
- W2100076167 hasLocation W21000761671 @default.
- W2100076167 hasLocation W21000761672 @default.
- W2100076167 hasOpenAccess W2100076167 @default.
- W2100076167 hasPrimaryLocation W21000761671 @default.
- W2100076167 hasRelatedWork W1988165869 @default.
- W2100076167 hasRelatedWork W2013843275 @default.
- W2100076167 hasRelatedWork W2018195085 @default.
- W2100076167 hasRelatedWork W2020831729 @default.
- W2100076167 hasRelatedWork W2041883344 @default.
- W2100076167 hasRelatedWork W2056710240 @default.
- W2100076167 hasRelatedWork W2057852793 @default.
- W2100076167 hasRelatedWork W2161013025 @default.
- W2100076167 hasRelatedWork W2329976959 @default.
- W2100076167 hasRelatedWork W2403369066 @default.
- W2100076167 hasVolume "22" @default.
- W2100076167 isParatext "false" @default.
- W2100076167 isRetracted "false" @default.
- W2100076167 magId "2100076167" @default.
- W2100076167 workType "article" @default.